Cerebrovascular Disease: Quality of Life (CODE: QoL)

RecruitingOBSERVATIONAL
Enrollment

680

Participants

Timeline

Start Date

May 27, 2023

Primary Completion Date

April 30, 2028

Study Completion Date

June 30, 2028

Conditions
Quality of LifeStroke, AcuteSexual BehaviorStressCortisol ExcessIncontinence, UrinaryCaregiver BurdenTransient Ischemic AttackIntracerebral HemorrhageCerebrovascular Disorders
Interventions
DIAGNOSTIC_TEST

questionnaire, hair samples, blood samples, clinical exam

The following parameters will be sequentially assessed in caregivers and patients (baseline, at 3 months and at 12 months): 1) quality of life / functioning will be determined through questionnaires (SF-36, EQ-5DL, ECOG (Eastern Cooperative Oncology Group) / Karnofsky, Barthel Index, ICIQ) 2) stress levels \& anxiety levels, caregiver burden will be assessed by the following questionnaires: Distress Thermometer, SBQ-G, GAD-7, PHQ-9, PSS-10, ZBI, PAC. Cortisol will be measured in hair to indicate stress within the past 3 months \[18\]. Fasting glucose, lipid profiles and HbA1c along with blood count, sodium, potassium, creatinine, TSH (thyroid-stimulating hormone) will be measured in routine blood samples from patients at the time of clinical checkups. Blood pressure, pulse and BMI will be determined during clinical visit in patients and additionally in caregivers.

Trial Locations (1)

8091

RECRUITING

Department of Neurology, University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER